Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value:
$180.9K
Total Bought:
$38.5K
Total Sold:
$22.5K
Net Transaction:
+$16.1K
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Exelixis, Inc.(EXEL)965,866878,533-87,333$32.2K$32.4K17.93%+$272
United Therapeutics Corporation(UTHR)92,05798,228+6,171$32.5K$30.3K16.74%-$2.2K
Cardinal Health, Inc.(CAH)208,845188,745-20,100$24.7K$26.0K14.38%+$1.3K
Supernus Pharmaceuticals Inc0431,986+431,986$0$14.1K7.82%+$14.1K
Jazz Pharmaceuticals plc(JAZZ)105,803100,703-5,100$13.0K$12.5K6.91%-$528
Enanta Pharmaceuticals, Inc.(ENTA)2,117,3902,116,586-804$12.2K$11.7K6.46%-$491
GSK plc(GSK)0272,000+272,000$0$10.5K5.83%+$10.5K
Indivior Plc935,680965,368+29,688$11.6K$9.2K5.09%-$2.4K
Sanofi(SNY)149,196149,096-100$7.2K$8.3K4.57%+$1.1K
BioNTech SE(BNTX)88,66387,563-1,100$10.1K$8.0K4.41%-$2.1K
Avadel Pharmaceuticals0950,000+950,000$0$7.4K4.11%+$7.4K
Alkermes plc(ALKS)238,136207,822-30,314$6.8K$6.9K3.79%+$13
Vanda Pharmaceuticals Inc.(VNDA)378,762754,381+375,619$1.8K$3.5K1.91%+$1.6K
Mural Oncology Plc70,16370,263+100$226$890.05%-$137
Biogen Inc.(BIIB)108,9230-108,923$16.7K$0—-$16.7K
Page 1 of 1